Navigation
Welcome Address
On behalf of the Australian Controlled Release Society (OzCRS), we welcome you to the 2022 Drug Delivery Australia Annual Conference, being held in Adelaide at the University of South Australia, City West Campus. This year’s conference theme is ‘Pharmaceutical Delivery: Enabling Clinical Translation of New Medicines’. This is the first DDA in-person meeting after two years of virtual/online events due to the COVID pandemic responses, that made travel impossible, then very difficult – we are so pleased to be able to see everyone in person again!
Conference highlights include plenary talks from internationally recognised experts including; Prof Kathryn Whitehead (Carnegie Mellon University), Prof Maria Kavallaris (University of New South Wales), Prof Frank Caruso (The University of Melbourne) and Prof Hélder Santos (University of Groningen), along with many invited and contributed speakers and posters. We also have the MTPConnect pitch session to look forward to, showcasing the imagination of our emerging young scientists.
These events do not occur without the support of the local community, but also our sponsors, including BioCina and UniSA Clinical and Health Sciences (Platinum), ATA Scientific and Mayne Pharma (Gold), MMIC (Conference dinner) as well as UniSA Ventures, Numedico, Madderns, MDPI and MTPConnect. We would like to take this opportunity to thank them all for supporting DDA2022!
We are excited to be holding the conference cocktail function Thursday night at the new Sky City Sol Rooftop located atop the iconic Eos Hotel. This will be a wonderful opportunity for conference delegates to network in a relaxed atmosphere. Don’t forget to make the most of the photobooth available on the night!
The venue, University of South Australia, City West Campus, is conveniently located in the Adelaide CBD;
numerous shops, cafés and restaurants are in close proximity, as are other attractions such as the Adelaide Zoo, the Torrens river and parklands as well as the Adelaide Oval.
We hope you enjoy your time in Adelaide for DDA 2022.
Clive Prestidge, Sanjay Garg and Tim Barnes (Conference Co-Chairs)
Information
Registration & Opening Remarks | |||
Time & Location: 8:30 am – 10 am, Hawke Building, Allan Scott Auditorium (Ground Level) | |||
8:30 am | Conference Registrations Open | ||
9:30 am | Welcome from DDA Chair & House Keeping – Prof. Clive Prestidge | ||
9:35 am | Welcome from University of South Australia DVCRE – Prof. Marnie Hughes-Warrington | ||
9:40 am | SA Chief Scientist Address – Prof. Caroline McMillen | ||
9:50 am | AusCRS Chair Welcome + Introduction | ||
PLENARY TALK – Prof. Kathryn Whitehead | |||
Time & Location: 10 am – 10:50 am, Hawke Building, Allan Scott Auditorium (Ground Level) | |||
Chair: TBC | |||
10:00 am | PLENARY: Prof. Kathryn Whitehead – Carnegie Mellon University | ||
Lipid nanoparticles for RNA delivery: Enablers of a new wave of genetic medicine | |||
10:50 am | Morning Tea & Poster Set Up – Hawke Building, Level 5, Bradley Forum (H5-01) | ||
SESSION 1 | |||
Time & Location: 11:20 am – 1:05 pm, Sir Hans Heysen Lecture Theatres | |||
Session 1A: Nanomedicine | Session 1B: Vaccines and Gene Therapy | ||
HH Lecture Theatre, Level 4 (HH4-08) | HH Lecture Theatre, Level 5 (HH5-08) | ||
Chairs: A/Prof. Anton Blencowe & Dr. Candace Day | Chairs: Prof. Alan Boddy & A/Prof. Ana Melero | ||
11:20 am | Invited: A/Prof. Amirali Popat | 11:20 am | Invited: Prof. Nicholas Voelcker |
University of Queensland | Monash University | ||
Mesoporous silica nanoparticles for overcoming multiple biological barriers | Gene delivery using silicon nanoneedle technology | ||
11:35 am | Invited: Dr. Alf Garcia Bennett | 11:35 am | Invited: Prof. Wojciech Chrzanowski |
Macquarie University | University of Sydney | ||
Physical and biological properties of the protein corona mesoporous silica particles | Extracellular vesicles as the next generation therapeutics and drug delivery vehicles: new hope or hype? | ||
11:50 am | Invited: Dr. Tushar Kumeria | 11:50 am | Invited: Dr. Adam Tilley |
UNSW Sydney | CSL Innovation | ||
Porous Silicon based Drug Delivery and Bioimaging Agents | Product Development Opportunities in ex-vivo Cell & Gene Therapy | ||
12:05 pm | Talk 1: Ms. Mitra Hosseini | 12:05 pm | Talk 1: Dr. Mariusz Skwarczynski |
University of South Australia | University of Queensland | ||
Design of lipid nanoparticles (LNPs) for effective gene delivery | Oral and Injectable Peptide-based Vaccines against Hookworm | ||
12:15 pm | Talk 2: Dr. Michael Lau | 12:15 pm | Talk 2: Dr. Hao Song |
Macquarie University | University of Queensland | ||
Exploring formulations of probucol using mesoporous silica particles | Nature-Inspired Nanoparticles for Gene and Vaccine Delivery | ||
SESSION 1 | |||
Time & Location: 11:20 am – 1:05 pm, Sir Hans Heysen Lecture Theatres | |||
Session 1A: Nanomedicine | Session 1B: Vaccines and Gene Therapy | ||
HH Lecture Theatre, Level 4 (HH4-08) | HH Lecture Theatre, Level 5 (HH5-08) | ||
Chairs: A/Prof. Anton Blencowe & Dr. Candace Day | Chairs: Prof. Alan Boddy & Dr. Thao Nguyen | ||
11:20 am | Invited: A/Prof. Amirali Popat | 11:20 am | Invited: Prof. Nicholas Voelcker |
University of Queensland | Monash University | ||
Mesoporous silica nanoparticles for overcoming multiple biological barriers | Gene delivery using silicon nanoneedle technology | ||
11:35 am | Invited: Dr. Alf Garcia Bennett | 11:35 am | Invited: Prof. Wojciech Chrzanowski |
Macquarie University | University of Sydney | ||
Physical and biological properties of the protein corona mesoporous silica particles | Extracellular vesicles as the next generation therapeutics and drug delivery vehicles: new hope or hype? | ||
11:50 am | Invited: Dr. Tushar Kumeria | 11:50 am | Invited: Dr. Adam Tilley |
UNSW Sydney | CSL Innovation | ||
Porous Silicon based Drug Delivery and Bioimaging Agents | Product Development Opportunities in ex-vivo Cell & Gene Therapy | ||
12:05 pm | Talk 1: Dr. Helen Xu | 12:05 pm | Talk 1: Dr. Mariusz Skwarczynski |
University of Technology Sydney | University of Queensland | ||
Smart drug delivery system of upconversion nanoparticles coated with mesoporous silica for controlled release | Oral and Injectable Peptide-based Vaccines against Hookworm | ||
12:15 pm | Talk 2: Dr. Michael Lau | 12:15 pm | Talk 2: Dr. Hao Song |
Macquarie University | University of Queensland | ||
Exploring formulations of probucol using mesoporous silica particles | Nature-Inspired Nanoparticles for Gene and Vaccine Delivery | ||
12:25 pm | Talk 3: Ms. Taskeen Janjua | 12:25 pm | Talk 3: Ms. Yuening Zhong |
University of Queensland | Australian Institute for Bioengineering and Nanotechnology; UQ | ||
Efficient Brain Delivery of Temozolomide using Ultrasmall Large Pore Silica Nanoparticles | Pathogen-Mimicking Bacterial Outer Membrane Coated Spiky Silica Nanoparticles for SARS-CoV-2 Vaccine Delivery | ||
12:35 pm | Talk 4: Dr. Aria Ahmed-Cox | 12:35 pm | Talk 4: Miss Gayathri S |
Children’s Cancer Institute; UNSW Sydney | University of Queensland | ||
Strategies for the quantitative visualisation of nanoparticle delivery in two aggressive brain cancers | Biologics as Peptide Delivery Vehicles for Immunotherapy | ||
12:45 pm | Talk 5: Dr. Thao Nguyen | 12:45 pm | Talk 5: Dr. Jie Tang |
University of South Australia | Australian Institute for Bioengineering and Nanotechnology; UQ | ||
Nanomedicine-based approaches to treat acute myeloid leukaemia | A mesoporous aluminosilicates nanoadjuvant to stimulate pyroptosis dependant immunity for cancer vaccine development | ||
12:55 pm | Talk 6: Miss Isabella Revesz | 12:55 pm | Talk 6: Dr. Rachel Stephenson |
University of South Australia | The University of Queensland | ||
Designing lipid-based nanocarriers of γδ T cell agonists for improved T-cell immunotherapy | Synthetic anti-cocaine nano-vaccine induces high titers of IgG and successfully prevents cocaine induced hyperlocomotion | ||
1:05 pm | Lunch & Poster Session – Hawke Building, Level 5, Bradley Forum (H5-01) | ||
*Sponsor Soap Box Session hosted by BioCina* | |||
KEYNOTE TALK – Prof. Maria Kavallaris | |||
Time & Location: 2:05 pm – 2:35 pm, Sir Hans Heysen Lecture Theatre, Level 5 (HH5-08) | |||
Chair – Prof. Sanjay Garg | |||
2:05 pm | KEYNOTE: Prof. Maria Kavallaris – UNSW Sydney | ||
Personalising cancer nanomedicine | |||
SESSION 2 | |||
Time & Location: 2:35 pm – 3:40 pm, Sir Hans Heysen Lecture Theatres | |||
Session 2A: Nanomedicine | Session 2B: Antimicrobials | ||
HH Lecture Theatre, Level 4 (HH4-08) | HH Lecture Theatre, Level 5 (HH5-08) | ||
Chairs: Prof. Hélder Santos & Ms. Riya Khetan | Chairs: Prof. Wojciech Chrzanowski & Dr. Tushar Kumeria | ||
2:35 pm | Invited: Prof. Killugudi Swaminatha Iyer | 2:35 pm | Invited: Dr. Hanif Haidari |
University of Western Australia | University of South Australia | ||
Single Cell Multiplex Sequencing for High Throughput and High Content Drug Screening | Bacteria-Activated Smart Antibacterial Hydrogel with On-Demand Release Based on Wound Microenvironment Changes | ||
2:50 pm | Talk 1: Dr. Andrew Care | 2:50 pm | Talk 1: Ms. Santhni Subramaniam |
University of Technology Sydney | University of South Australia | ||
Engineering protein nanocages for nanomedicine: From rapid prototyping strategies to in vitro and in vivo delivery | Nanoantibiotics against intracellular bacteria: Influence of biological molecules on performance of lipid nanocarriers | ||
3:00 pm | Talk 2: Dr. Wye Khay Fong | 3:00 pm | Talk 2: Mr. Muhammed Awad |
University of Newcastle | University of South Australia | ||
The effect of surfactants on the in vitro behaviour of suppositories: spontaneous structure formation and solubility | Gallium protoporphyrin lipid liquid crystalline nanoparticles a third generation photosenstizer against bacterial biofilms | ||
3:10 pm | Talk 3: Mr. Christopher Subasic | 3:10 pm | Talk 3: Mr. Wenbin Huang |
University of Queensland | University of Queensland | ||
PEGylated liposome encapsulation reduces brain biodistribution of the hydrophobic phenothiazine, prochlorperazine | Investigation of the structure-activity relationship of cyclic peptide, lipid, and antigen-induced high titers of opsonic IgG antibodies against Group A Streptococcus | ||
3:20 pm | Talk 4: Mr. Isaac Rad | 3:20 pm | Talk 4: Mr. Lantian Lu |
University of Queensland | University of Queensland | ||
Developing a novel acoustofluidic platform for rapid, targeted posterior eye delivery of therapeutics | Poly(hydrophobic amino acids) as promising immunopotentiators to enhance humoral responses against Group A Streptococcus | ||
3:30 pm | Talk 5: Miss Brooke Bonnell | 3:30 pm | Talk 5: Dr. Candace Day |
Macquarie University | University of South Australia | ||
Development of an intranasal brain delivery nanogel for treatment of Alzheimer’s Disease | Effects of Aqueous Dispersing Matrix on the Gelation and Stability of APIs in Otitis Formulations | ||
3:40 pm | Afternoon Tea – Bradley Building, Level 8 (HB8-18) | ||
MTPConnect Pitch Session | |||
Chair: Prof. Clive Prestidge | |||
Judges: Mr. Ian Wisenberg (BioCina), Dr. Thomas Ting (UniSA Ventures) & Mr. Angelo Lepore (Mayne Pharma | |||
Time & Location: 4:15 pm – 5:45 pm, Bradley Building, Level 8 (HB8-18) | |||
AusCRS AGM | |||
Time & Location: 5:45 pm – 6:20 pm, Bradley Building, Level 8 (HB8-18) | |||
CONFERENCE DINNER | |||
Venue: Sôl Rooftop Bar, Level 9, SkyCity Adelaide | |||
Cocktail Dinner | |||
Email: enquiries@solrooftop.com.au | |||
Website: www.skycityadelaide.com.au/eat-and-drink/sôl-rooftop/ | |||
Time: 6:30 pm – 10:30 pm | |||
Day 2: Friday 25th November | |||
8:00 am | Tea & Coffee Available – Hawke Building, Level 5, Bradley Forum (H5-01) | ||
PLENARY TALK – Prof. Frank Caruso | |||
Time & Location: 9:00 am – 9:50 am, Hawke Building, Allan Scott Auditorium (Ground Level) | |||
Chair: Dr. Tim Barnes | |||
9:00 am | PLENARY: Prof. Frank Caruso– The University of Melbourne | ||
Nanoengineering Particles for Therapeutic Delivery | |||
RAPID FIRE TALKS | |||
Time & Location: 9:50 am – 10:35 am, Hawke Building, Allan Scott Auditorium (Ground Level) | |||
Chairs: Prof. Ben Boyd & Dr. Kristen Bremmell | |||
2 minute presentation + 1 minute questions | |||
Talk 1 | Mr. Christopher Subasic – Off-target effects of phenothiazine-mediated dynamin II inhibition on peripheral white blood cell liposome uptake | ||
Talk 2 | Ms. Letao Xu – Lipid-based nanoparticles with high drug loading for drug delivery | ||
Talk 3 | Miss Cintya Dharmayanti – Development of modular pH-responsive polymeric micelles for targeted endosomal drug release | ||
Talk 4 | Ms. Leah Wright – A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems | ||
Talk 5 | Mr. Ravi Raj – Nanomedicine and Gene Therapy to Treat Glioblastoma | ||
Talk 6 | Ms. Lutfun Neesa – Development of a progesterone nanoformulation towards improved vaginal delivery and management of preterm birth | ||
Talk 7 | Ms. Sue Lyn Yap – Cellular Uptake of Lipid Nanoparticles in Various Crystalline Phases | ||
Talk 8 | Mr. Liam Krueger – 3D printed caffeine tablets for personalised dose titration | ||
Talk 9 | Mr. Limin Dai – Development of recombinant and synthetic, multicomponent tumor-targeted gene delivery platform | ||
Talk 10 | Miss Jingwen Wang– Development of poly(hydrophobic amino acid)-based liposomal delivery systems for vaccine against Group A Streptococcus | ||
10:35 am | Morning Tea – Hawke Building, Level 5, Bradley Forum (H5-01) | ||
SESSION 3 | |||
Time & Location: 11:10 am – 12:40 pm, Sir Hans Heysen Lecture Theatres | |||
Session 3A: Nanomedicine | Session 3B: Innovation in Drug Delivery | ||
HH Lecture Theatre, Level 4 (HH4-08) | HH Lecture Theatre, Level 5 (HH5-08) | ||
Chairs: Prof. Benjamin Thierry & Dr. Hao Song | Chairs: Dr. Paul Joyce & Dr. Tahlia Meola | ||
11:10 am | Invited: Prof. Ben Boyd | 11:10 am | Invited: A/Prof. Ana Melero |
Monash University | University of Valencia | ||
Developments in metabolic labelling as a new approach to localised drug delivery via antibody-free ‘cellular Velcro’ | Challenges and Solutions for skin drug delivery | ||
11:25 am | Invited: A/Prof. Anton Blencowe | 11:25 am | Invited: Dr. Orlagh Feeney |
University of South Australia | Monash University | ||
Teaching an old dog new tricks: Rendering non-responsive micelles pH-responsive through the incorporation of oligoelectrolytes | Directing polymeric and macromolecular therapeutics to the lymphatics to treat lymph-resident disease | ||
11:40 am | Invited: Dr. Peter Wich | 11:40 am | Invited: Dr. Kara Perrow |
UNSW Sydney | University of Wollongong | ||
Biohybrid Polysaccharide Nanomaterials for Drug Delivery | Developing localised drug delivery strategies to target the tumour microenvironment | ||
11:55 am | Talk 1: Dr. Anthony Day | 11:55 am | Talk 1: A/Prof. Cornelia Keck |
UNSW Sydney | Philipps University of Marburg | ||
Glycoluril-based molecular hosts as drug delivery vehicles | Novel insights into dermal drug delivery | ||
12:05 pm | Talk 2: Mr. Franco Centurion | 12:05 pm | Talk 2: Prof. Simon Moulton |
UNSW Sydney | Swinburne University of Technology | ||
Cell-mediated biointerfacial phenolic assembly for probiotic nano encapsulation | Active and Passive drug release by self-assembled lubricin (PRG4) anti-fouling coatings | ||
12:15 pm | Talk 3: Dr. Guangze Yang | 12:15 pm | Talk 3: Ms. Fatima Abid |
University of Adelaide | University of South Australia | ||
Implications of Quenching-to-Dequenching Switch in Quantitative Cell Uptake and Biodistribution of Dye-Labelled Nanoparticles | A novel pH-buffered gel for cutaneous wound healing | ||
12:25 pm | Talk 4: Dr. Yun Liu | 12:25 pm | Talk 4: Dr. Franklin Afinjuomo |
University of Adelaide | University of South Australia | ||
Monitoring of Drug Release from Nanoparticles with High Drug Loading by FRET-based methods | Inulin dialdehyde crosslinked gelatin hydrogels for drug delivery applications | ||
12:35 pm | Talk 5: Ms. Diviya Santhanes | 12:35 pm | Talk 5: Ms. Souha Youssef |
University of Newcastle | University of South Australia | ||
Microfluidic formulation of lipid/ polymer hybrid nanoparticles for plasmid DNA (pDNA) delivery | Development of 3D printed scaffolds for targeted delivery of combinational chemotherapy | ||
12:45 pm | Lunch & Poster Session – Hawke Building, Level 5, Bradley Forum (H5-01) | ||
*Pack up poster at end of session* | |||
KEYNOTE TALK – Prof. Hélder Santos | |||
Time & Location: 1:45 pm – 2:15 pm, Sir Hans Heysen Lecture Theatre, Level 5 (HH5-08) | |||
Chair: A/Prof. Amirali Popat | |||
1:45 pm | KEYNOTE: Prof. Hélder Santos – University of Groningen | ||
Nanoparticles for cancer immunotherapy and cardiac repair: from design towards clinical applications | |||
SESSION 4 | |||
Time & Location: 2:15 pm – 3:35 pm, Sir Hans Heysen Lecture Theatres | |||
Session 4A: Vaccines and Gene Therapy | Session 4B: Oral Drug Delivery | ||
HH Lecture Theatre, Level 4 (HH4-08) | HH Lecture Theatre, Level 5 (HH5-08) | ||
Chairs: Dr. Khay Fong & Ms. Santhni Subramaniam | Chairs: Dr. Orlagh Feeney & Ms. Fatima Abid | ||
2:15 pm | Invited: Prof. Chunxia Zhao | 2:15 pm | Invited: Dr. Paul Joyce |
University of Adelaide | University of South Australia | ||
Platform technologies for cancer nanomedicine | Targeting the gut microbiome through novel formulation strategies | ||
2:30 pm | Invited: Prof. Jingjing Wan | 2:30 pm | Invited: Prof. Charlotte Conn |
East China Normal University | RMIT University | ||
Effective nano-agonists for anti-tumoral activation of tumor-associated macrophages | Lipid Nanomaterials for Oral Delivery of Biopharmaceuticals | ||
2:45 pm | Talk 1: Dr. Zerong Ma | 2:45 pm | Talk 1: Miss Yuxue Cao |
Children’s Cancer Institute; UNSW Sydney | University of Queensland | ||
Miktoarm star polymer nanoparticles act as effective siRNA delivery vehicles to lung cancer cells to delay tumour growth in orthotopic lung cancer mouse models | Virus Like Silica nanoparticles for oral insulin delivery | ||
2:55 pm | Talk 2: Mr. Gabriele De Rubis | 2:55 pm | Talk 2: Dr. Md Moniruzzaman |
University of Technology Sydney | University of Queensland | ||
Anticancer activity of NFκB decoy oligonucleotide encapsulated polysaccharide-based nanoparticles against human lung adenocarcinoma | Enhancing the efficacy of cannabidiol using protein nanoparticle to treat inflammatory bowel disease | ||
3:05 pm | Talk 3: Ms. Amy Logan | 3:05 pm | Talk 3: Ms. Vicky Barmpatsalou |
Children’s Cancer Institute; UNSW Sydney | Uppsala University | ||
Targeted “plug and play” lipid nanoparticles improve siRNA delivery and gene silencing in neuroblastoma | Development and validation of a porcine artificial colonic mucus model reflecting the properties of native colonic mucus in pigs | ||
3:15 pm | Talk 4: Dr. Mélodie Migault | 3:15 pm | Talk 4: Mr. Wenhuang Ban |
University of South Australia | Australian Institute for Bioengineering and Nanotechnology; UQ | ||
Co-operative small interfering RNAs: a promising strategy to treat metastatic melanoma. | Lipase Powered Asymmetric Silica Nanomotors for Enhanced Mucus Penetration | ||
3:25 pm | Talk 5: Ms. Feifei Liu | 3:25 pm | Talk 5: Mr. Ahmed Abdulrahman |
The University of Queensland | UNSW Canberra | ||
Glypican-1 targeting polymeric micelle for delivery of immune-boosting peptides to manage lung cancer | Cucurbituril as oral drug delivery vehicles | ||
CLOSING REMARKS | |||
Time & Location: 3:35 pm – 3:50 pm, Sir Hans Heysen Lecture Theatre, Level 5 (HH5-08) | |||
MTPConnect Pitch Session
Adelaide Intermediary Program- Pitch’n’Win Session
Drug delivery australia conference 24-25 november 2022
Date: 24 November, 2022 4pm-5:30pm
Chair: Dana Bell, Innovation and Translation Intermediary, MTPConnect
Format: 3min pitch, 3min feedback, audience voting and Award Presentation
Panel:
Ian Wisenberg Chief Executive Officer, BioCina
Angelo Lepore Formulation Team Leader, Mayne Pharma
Dr Thomas Ting Deputy Director – Commercialisation, University of South Australia
Presenters:
Thao Nguyen |
|
Nanomedicine-based approaches to eradicate cancer relapse driving stem cells |
Hao Song |
|
Packing mRNA into an oral tablet |
Paul Joyce |
|
Sandy pills for curing obesity |
Liam Krueger |
|
3D printing for precise dose titration |
Candace Day |
|
Sweet Little Mushrooms: The Aroma of Magic! |
Isabella Revesz |
|
Lipid nanoparticle delivery of targeted phosphoantigens for an “off-the-shelf” T-cell Immunotherapy |
Taskeen Janjua |
|
Cannabidiol for Brain cancer |
Prize: One winner of the
Pitch’n’Win Session will be awarded with a certificate, one entry position to
participate in the Bridge Program 2023, and up to $1000 to be used for travel
and accommodation to attend face-to-face Bridge Program hosted events and
workshops. **(note instructions on redeeming money for travel and
accommodation)**
About the
Bridge Program
The Bridge Program
provides training to help participants effectively navigate the pharmaceutical
commercialisation pathway. It is suited to mid-career professionals looking to
expand their commercialisation knowledge and networks. For more information
visit The Bridge Program.
About the Adelaide Intermediary Program:
Researchers, innovators, and organisations are invited to connect to MTPConnect’s Adelaide Intermediary Program and access services to accelerate health and medical research, innovation, and translation in SA. Leveraging the strengths of Adelaide BioMed City and across the State, the program focuses on creating connections that drive new opportunity – locally, nationally and globally to empower the Health Medical Innovation ecosystem.
Connect with the team to leverage their depth of knowledge and networks. Services include expert advice, funding opportunity identification, strategic introductions, proposal reviews and more.
For more information, visit MTPConnect/Adelaide Intermediary Program
Conference Housekeeping
- If you need assistance throughout the conference, please approach one of our friendly organising committee members and event helpers.
- Organising Committee Members will have a GREEN DOT on their name tags
- Event Helpers will have a BLUE DOT on their name tags
- Those who are attending the conference dinner will have a conference dinner name tag, marked by a RED DOT and the logo of our conference dinner sponsor (Monash University MMIC). Please show this name tag on arrival to the conference.